...
首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays
【24h】

Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays

机译:HLA I类抗原表位在Ig结合,C1q结合和淋巴细胞毒性试验中与人单克隆抗体反应的结构方面

获取原文
获取原文并翻译 | 示例

摘要

This study addresses the reactivity patterns of human cytotoxic HLA class I epitope-specific monoclonal antibodies in Ig-binding and complement component C1q-binding Luminex assays in comparison with complement-dependent lymphocytotoxicity data reported at the 13th International HLA Workshop. Some monoclonal antibodies reacted similarly with epitope-carrying alleles in all three assays but others showed different reactivity patterns. These reactivity differences were analyzed with HLAMatchmaker and we incorporated the concept that eplets are essential parts of structural epitopes which can contact the six Complementarity Determining Regions (CDRs) of antibody. The data show that technique-dependent reactivity patterns are associated with distinct differences between polymorphic amino acid configurations on eplet-defined structural epitopes.The findings have been viewed in context of antigen-antibody complex formation that results in the release of free energy necessary to stabilize binding and to induce conformational changes in the antibody molecule to expose the C1q binding site, the first step of complement activation. Moreover the amount of free energy should be sufficient to induce a conformational change of C1q thereby initiating the first stages of the classical complement cascade leading to lymphocytotoxicity. The complement-fixing properties of HLA antibodies require not only specific recognition of eplets but also depend on interactions of other CDRs with critical amino acid configurations within the structural epitope. Eplet-carrying alleles that lack such configurations may only bind with antibody. This concept is important to our understanding whether or not complement-fixing donor-specific HLA antibodies can initiate antibody-mediated rejection.
机译:这项研究与在第13届国际HLA研讨会上报告的补体依赖性淋巴细胞毒性数据相比,解决了Ig结合和补体成分C1q结合Luminex分析中人细胞毒性HLA I类表位特异性单克隆抗体的反应模式。在所有三种测定中,一些单克隆抗体与携带抗原决定簇的等位基因反应相似,但其他单克隆抗体表现出不同的反应模式。使用HLAMatchmaker分析了这些反应性差异,并且我们引入了概念,即小分子是结构表位的重要组成部分,可以与抗体的六个互补决定区(CDR)接触。数据表明,依赖技术的反应模式与eplet定义的结构表位上的多态性氨基酸构型之间的明显差异有关。在抗原-抗体复合物形成的背景下观察到了这一发现,该结果导致释放稳定所需的自由能结合并诱导抗体分子构象变化以暴露C1q结合位点,这是补体激活的第一步。此外,自由能的量应足以引起C1q的构象变化,从而引发经典补体级联反应的第一阶段,导致淋巴细胞毒性。 HLA抗体的补体固定特性不仅需要对小片段的特异性识别,而且还取决于其他CDR与结构表位中关键氨基酸构型的相互作用。缺少这种构型的携带小片段的等位基因只能与抗体结合。这个概念对于我们理解补体固定供体特异性HLA抗体是否可以启动抗体介导的排斥反应很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号